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Reply to the Editor:
We thank Dr Raja for his supportive com-
ments and we agree with the additional
advantages offered by skeletonizing the in-
ternal thoracic artery (ITA) for grafting
stated in his letter. In particular, the addi-
tional length gained by skeletonization is
extremely helpful when the right ITA is
used as an in situ graft to obtuse marginal
branches of the circumflex coronary ar-
tery.1
Dr Raja correctly notes that skeletoniza-
tion of ITAs requires more technical exper-
tise and time than does conventional pedi-
cled harvesting. Although the total
operative times were similar for the skele-
tonized and conventional groups in our
study,2 skeletonization may add 10 to 20
minutes to the ITA harvesting time. The
surgeons in our study felt proficient with
skeletonization after approximately 20 ITA
harvests. Injury to the ITA during this
learning phase is a concern, but we did not
record the frequency of ITA injury in our
database. If an ITA graft is injured during
harvesting, we can occasionally utilize the
undamaged segment as a free graft. The
surgeons who routinely perform skeleton-
ization at our institution report a very low
(1%) incidence of ITA injury. Unfortu-
nately, most studies in the literature do not
report the incidence of injury to the ITA
graft during skeletonization; however,ThNishida and colleagues3 reported an inci-
dence of 0.7%.
Dr Raja also raises the concern that
manipulation of the ITA graft during skel-
etonization may contribute to an increased
propensity toward graft spasm. Spasm of
the ITA graft has been reported in the lit-
erature, and some institutions inject the
ITA with papaverine to prevent spasm.
However, intraluminal injection of vasodi-
lating agents can itself lead to graft injury
by pressurizing the artery, resulting in en-
dothelial damage or dissection. Instead, we
prefer to bathe skeletonized ITAs with top-
ical papaverine. Although we do not ac-
tively record the incidence of postoperative
ITA spasm in our institution, we do know
that it is uncommon.
We believe that meticulous ITA skel-
etonization offers many advantages relative
to pedicled harvesting, with an acceptably
low risk of complications.
Mark D. Peterson, MDa,b
Michael A. Borger, MD, PhDa,b
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A lost opportunity
To the Editor:
In the article “Neurodevelopmental Status
at Eight Years in Children with Dextro-
transposition of the Great Arteries: The
Boston Circulatory Arrest Trial,” Bellinger
and colleagues1 presented a sophisticated
prospective randomized study, with an ex-
e Journal of Thoracic and Cardiovascular Stensive data collection and analysis. How-
ever, they limited their investigations to
“the two major methods of vital organ sup-
port, total circulatory arrest and low-flow
cardiopulmonary bypass.” I respectfully
disagree with Bellinger and colleagues’ de-
cision, because they wasted a good oppor-
tunity by using a tremendous amount of
effort and expertise to evaluate two meth-
ods already proven to provide suboptimal
results. In my opinion, comparing total cir-
culatory arrest and low-flow cardiopulmo-
nary bypass is like comparing two different
brands of cigarettes to evaluate whether
one is less dangerous than the other.
There are already too many experimen-
tal and clinical studies reported in the lit-
erature on how to reduce the negative ef-
fects of hypothermia or flow reduction:
metabolic derangement; endothelial le-
sions; and vascular, myocardial, neuro-
logic, hematologic, and respiratory impair-
ment.2,3 Instead of investing their
extraordinary resources in this type of re-
search, Bellinger and colleagues could ex-
plore an alternative method of cardiopul-
monary bypass, even if they do not
consider it to be one of the “two major
methods of vital organ support”: normo-
thermic high-flow cardiopulmonary by-
pass.3,4 This method has already been sup-
ported by clinical experience with more
than 1600 cases of surgery for congenital
heart disease, including the arterial switch
operation for neonates with transposition of
the great arteries.4
The readers involved with the surgical
treatment of children with congenital heart
disease should be aware that we as sur-
geons are not obliged to choose between
suboptimal methods of cardiopulmonary
bypass, much as we are not obliged to
choose among different brands of ciga-
rettes if we are not smokers. There is the
proven possibility of performing cardiopul-
monary perfusion much closer to the phys-
iologic state,4 and research units like the
one of this study could use their resources
to compare the “two major methods of vital
organ support” with a more physiologically
compatible method.
Antonio F. Corno, MD, FRCS, FETCS
Cardiovascular Surgery
Centre Hospitalier Universitaire Vaudois
(CHUV)
46 rue du Bugnon
CH-1011, Lausanne, Switzerland
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Reply to the Editor:
We thank Dr Corno for his suggestion that
normothermic high-flow cardiopulmonary
bypass would be likely to improve neuro-
developmental outcome relative to circula-
tory arrest or hypothermic reduced flow
bypass, the two techniques that we studied.
We agree with Dr Corno that many perfu-
sion variables may influence late develop-
mental outcome, and we recognize that few
of these have been studied in detail. The
Boston Circulatory Arrest Study, the sub-
ject of our recent report, was designed in
1987. Since that time, our laboratory stud-
ies have led us to undertake two subsequent
prospective randomized clinical trials, one
studying the role of pH1 and one studying
the role of hematocrit in influencing out-
2come after cardiopulmonary bypass. Both
1858 The Journal of Thoracic and Cardiovtrials confirmed our laboratory results and
resulted in important changes in our tech-
nique of bypass. However, our more recent
laboratory studies investigating different
temperature strategies for cardiopulmonary
bypass have suggested that there is a dis-
advantage in using a higher temperature for
cardiopulmonary bypass. For example, in a
study that used intravital microscopy for
direct examination of the cerebral micro-
circulation, we observed greater activation
of white cells with increased numbers of
rolling and adherent white cells when car-
diopulmonary bypass was conducted at
34°C than at 15°C.3 We believe that this
result reflects the fact that, despite Dr Cor-
no’s assertion to the contrary, cardiopul-
monary bypass remains far from being a
physiologic state. It is widely known that
cardiopulmonary bypass is associated with
multiple systemic inflammatory effects,
both humoral and cellular. Our laboratory
study has confirmed that a higher temper-
ature exacerbates this inflammatory re-
sponse. In addition, the high flow rate that
is required to support the greater metabolic
rate associated with a higher temperature
also carries many disadvantages, including
increased generation of emboli, increased
left heart return necessitating greater suc-
tion volumes, reduced intracardiac expo-
sure because of the need for multiple can-
nulas and increased left heart return, less
effective myocardial protection with need
for multiple reinfusions of cardioplegia
(demonstrated to be a disadvantage in the
neonate), and a reduced margin for safety
in the event of equipment failure. The the-
ascular Surgery ● June 2004oretical disadvantages of increased infec-
tion and bleeding that might result from
hypothermia have not been confirmed in
the neonate and infant.
In conclusion, we hope that Dr Corno
and his associates will have the opportunity
in the future to undertake developmental
studies of their many patients who undergo
normothermic high-flow bypass. Our own
clinical studies will continue to be guided
by translational research undertaken in the
laboratory, which to date has not indicated
any advantage for normothermic high-flow
bypass.
Richard A. Jonas, MD
Jane W. Newburger, MD, MPH
David C. Bellinger, PhD, MSc
Children’s Hospital Boston
Harvard Medical School
Boston, MA 02115
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